Advanced search×

Evaluation of central corneal thickness measurement with RTVue spectral domain optical coherence tomography in normal subjects.

Harsha Laxmana Rao, Addepalli Uday Kumar, Anjul Kumar, Swathi Chary, Sirisha Senthil, Pravin Krishna Vaddavalli, and Chandra Sekhar Garudadri

Cornea 30(2):121-6 (2011) PMID 20885314

To determine (1) repeatability of central corneal thickness (CCT) measurements by spectral domain optical coherence tomography (RTVue; Optovue, Inc, Fremont, CA) and (2) agreement between CCT measurements by RTVue and those by ultrasonic pachymetry, Orbscan, and anterior segment optical coherence tomography (ASOCT).

DOI: 10.1097/ICO.0b013e3181e16c65
Version: za2963e q8zaf q8zb1 q8zc4 q8zd2 q8ze0 q8zfe q8zg5

Similar articles you may find interesting…

  1. Ultrasound biomicroscopy in two cases of ocular siderosis with secondary glaucoma.
    Chiara C Sangermani, Paolo P Mora, ... Stefano A SA Gandolfi

    Audio, Transactions of the IRE Professional... 88(1):e1-2 (2010) PMID 19563373

  2. Improvement of spatial contrast sensitivity threshold after surgical reduction of intraocular pressure in unilateral high-tension glaucoma.
    Stefano A Gandolfi, Luca Cimino, ... Maria Grazia Tardini

    Invest Ophthalmol Vis Sci 46(1):197-201 (2005) PMID 15623774

    Eyes with no field defects on white-on-white computer-assisted static perimetry, but bearing a IOP > or = 30 mmHg, show a decreased spatial contrast sensitivity. A surgically obtained reduction of IOP is paralleled by an improvement of spatial contrast sensitivity....
  3. Bronchial reactivity in healthy individuals undergoing long-term topical treatment with beta-blockers.
    Stefano A SA Gandolfi, Alfredo A Chetta, ... Maria Grazia MG Tardini

    Arch Ophthalmol 123(1):35-8 (2005) PMID 15642809

    Healthy individuals who undergo long-term topical application of a nonselective beta-blocker (0.5% timolol) can develop a subclinical increase in bronchial reactivity. This phenomenon may not be completely reversible on withdrawal of the beta-blocker....